The University of Chicago Header Logo

Connection

Justin Levisay to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Justin Levisay has written about Treatment Outcome.
Justin Levisay
Connection Strength
0.372
Treatment Outcome
  1. Balloon Aortic Valvuloplasty Followed by Impella®-Assisted Left Main Coronary Artery Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis as a Bridge to Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2021 01; 22:16-21.
    View in: PubMed
    Score: 0.064
  2. Percutaneous vascular plug for incomplete surgical left atrial appendage closure. J Invasive Cardiol. 2014 Apr; 26(4):180-2.
    View in: PubMed
    Score: 0.042
  3. Antegrade approach for TAVR with total occlusion of the descending aorta. Catheter Cardiovasc Interv. 2014 Apr 01; 83(5):824-30.
    View in: PubMed
    Score: 0.041
  4. Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. J Invasive Cardiol. 2010 May; 22(5):216-9.
    View in: PubMed
    Score: 0.032
  5. Real-world application of CCTA with CT-FFR for coronary assessment pre-TAVI: the CT2TAVI study. Int J Cardiovasc Imaging. 2025 Mar; 41(3):523-535.
    View in: PubMed
    Score: 0.022
  6. One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk Patients. Circ Cardiovasc Interv. 2024 Aug; 17(8):e013782.
    View in: PubMed
    Score: 0.021
  7. Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. Catheter Cardiovasc Interv. 2023 07; 102(1):145-154.
    View in: PubMed
    Score: 0.020
  8. Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovasc Drugs Ther. 2024 Jun; 38(3):447-457.
    View in: PubMed
    Score: 0.019
  9. A Case of Valve-in-Valve-in-Valve for Severe Aortic Regurgitation: Is Lifetime Management Upon Us? Cardiovasc Revasc Med. 2023 08; 53S:S180-S183.
    View in: PubMed
    Score: 0.018
  10. 2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. JACC Cardiovasc Interv. 2021 07 26; 14(14):1538-1548.
    View in: PubMed
    Score: 0.017
  11. 1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. JACC Cardiovasc Interv. 2020 10 26; 13(20):2344-2357.
    View in: PubMed
    Score: 0.017
  12. Arterial Cutaneous Femoral Fistulous Tract Closure Using Surgiflo Hemostatic Matrix: A Novel Adjunct for Post-TAVR Access-Site Management. J Invasive Cardiol. 2017 Aug; 29(8):277-279.
    View in: PubMed
    Score: 0.013
  13. Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv. 2018 09 01; 92(3):E185-E196.
    View in: PubMed
    Score: 0.013
  14. MitraClip Therapy for Mitral Regurgitation: Secondary Mitral Regurgitation. Interv Cardiol Clin. 2016 01; 5(1):83-91.
    View in: PubMed
    Score: 0.012
  15. Low profile vascular plugs for paravalvular leaks after TAVR. Catheter Cardiovasc Interv. 2014 Feb; 83(2):280-8.
    View in: PubMed
    Score: 0.010
  16. High pacing rates for management of aortic insufficiency after balloon aortic valvuloplasty or transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014 Jan 01; 83(1):162-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.